Amlodipine besylate market is anticipated to grow at a considerable CAGR of 8.2% during the forecast period. Due to some restraint factors like drowsiness, loss of appetite, weight loss, high heart rate, and swollen gums are some of the side effects that are expected to slow the amlodipine besylate market’s growth. Patients don’t prefer the use of amlodipine besylate in their treatment due to the above-mentioned reasons. For instance, in January 2022, According to NCBI, at a dose of 10 mg of amlodipine besylate, the incidence of edema, dizziness, flushing, and palpitations was 10.8%, 3.4%, 2.6%, and 4.5%, respectively. In addition, the incidence of headaches, fatigue, nausea, and abdominal pain was 7.3%, 4.5%, 2.9%, and 1.6%, respectively. For instance, in January 2022 According to NCBI, as a compensatory mechanism, amlodipine overdose and toxicity can cause severe vasodilation, hypotension, and reflex tachycardia. Systemic hypotension that persists can lead to shock and possibly death. Patients who have taken too much amlodipine should be given activated charcoal (AC). Intravenous (IV) fluid resuscitation, IV calcium gluconate, and vasopressor therapy with norepinephrine or dopamine usually resolve the hypotension. High-dose insulin is occasionally used because studies have indicated that it reduces mortality and improves hemodynamics. During an overdose, electrocardiographic data, vital signs, kidney function, urine output, and electrolytes must all be closely monitored.
To Request a Sample of our Report on Amlodipine Besylate Market: https://www.omrglobal.com/request-sample/amlodipine-besylate-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Apotex Inc., Aurobindo Pharma Ltd., China Resources Pharmaceutical Group Ltd., Macleods Pharmaceuticals Ltd., Pfizer Inc., and others.
Amlodipine Besylate Market Report Segment
By Type
- 5mg Tablets
- 5mg Tablets
- 10mg Tablets
- By Material
- High Blood Pressure
- Heart Disease
A full Report of Amlodipine Besylate Market is Available @ https://www.omrglobal.com/industry-reports/amlodipine-besylate-market
Amlodipine Besylate Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Alkem Laboratories Ltd.
- Cipla Inc.
- Reddy’s Laboratories
- Epic Pharma, LLC
- Hikma Pharmaceuticals PLC
- Indizen Pharmaceutical Ltd.
- Lupin Pharmaceuticals Inc.
- Mylan Inc.
- Strides Pharma Science Ltd.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Upsher-Smith Laboratories, LLC
- Wockhardt Ltd.
- Zydus Pharmaceuticals Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
